Antiprotozoal Drugs Market - Global Outlook and Forecast 2022-2028

March 2022 | 116 pages | ID: A8FA7D771C35EN
Market Monitor Global

Abstracts

Antiprotozoal agents (ATC code: ATC P01) is a class of pharmaceuticals used in treatment of protozoan infection.

This report contains market size and forecasts of Antiprotozoal Drugs in Global, including the following market information:

Global Antiprotozoal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antiprotozoal Drugs market was valued at 17750 million in 2021 and is projected to reach US$ 22490 million by 2028, at a CAGR of 3.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Diseases Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antiprotozoal Drugs include Sanofi, Akthelia Pharmaceuticals Ltd, GlaxoSmithKline Plc, Immuron Ltd, Microbiotix Inc, Protein Potential LLC, Dr. Reddy’s Laboratories, Mission Pharmacal and Aceto Corp., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiprotozoal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiprotozoal Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antiprotozoal Drugs Market Segment Percentages, by Type, 2021 (%)

• by Diseases
• Amoebic Dysentery
• Antimalarial Drug
• Leishmaniasis & Chagas Disease
• by Drugs
• Metronidazole
• Atovaquone
• Benznidazole
• Dehydroemetine
• Eflornithine
• Emetine
• Fenbendazole
• Iodoquinol
• Melarsoprol
• Others (like Meglumine antimonite, Nifurtimox, Pentamidine, etc.)

Global Antiprotozoal Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antiprotozoal Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic

Global Antiprotozoal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antiprotozoal Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antiprotozoal Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antiprotozoal Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Akthelia Pharmaceuticals Ltd
• GlaxoSmithKline Plc
• Immuron Ltd
• Microbiotix Inc
• Protein Potential LLC
• Dr. Reddy’s Laboratories
• Mission Pharmacal
• Aceto Corp.
• Mylan Pharmaceuticals
• Impax Laboratories
• Pfizer
• Lupin Pharmaceuticals
• Glenmark Pharmaceuticals
• Sun Pharmaceutical
• Heritage Pharmaceuticals
• Gilead Sciences
• Johnson & Johnson
• Bristol-Myers Squibb
• Profounda
• Knight Therapeutics
• Albert David
• Wanlong
• Fangsheng
• KPC Pharmaceuticals
• Guilin Pharmaceuticals
• Pude Pharmaceutica

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antiprotozoal Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antiprotozoal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIPROTOZOAL DRUGS OVERALL MARKET SIZE

2.1 Global Antiprotozoal Drugs Market Size: 2021 VS 2028
2.2 Global Antiprotozoal Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antiprotozoal Drugs Players in Global Market
3.2 Top Global Antiprotozoal Drugs Companies Ranked by Revenue
3.3 Global Antiprotozoal Drugs Revenue by Companies
3.4 Top 3 and Top 5 Antiprotozoal Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antiprotozoal Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiprotozoal Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Antiprotozoal Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antiprotozoal Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antiprotozoal Drugs Market Size Markets, 2021 & 2028
  4.1.2 Amoebic Dysentery
  4.1.3 Antimalarial Drug
  4.1.4 Leishmaniasis & Chagas Disease
4.2 By Type - Global Antiprotozoal Drugs Revenue & Forecasts
  4.2.1 By Type - Global Antiprotozoal Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Antiprotozoal Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Antiprotozoal Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antiprotozoal Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
5.2 By Application - Global Antiprotozoal Drugs Revenue & Forecasts
  5.2.1 By Application - Global Antiprotozoal Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Antiprotozoal Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Antiprotozoal Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antiprotozoal Drugs Market Size, 2021 & 2028
6.2 By Region - Global Antiprotozoal Drugs Revenue & Forecasts
  6.2.1 By Region - Global Antiprotozoal Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Antiprotozoal Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Antiprotozoal Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antiprotozoal Drugs Revenue, 2017-2028
  6.3.2 US Antiprotozoal Drugs Market Size, 2017-2028
  6.3.3 Canada Antiprotozoal Drugs Market Size, 2017-2028
  6.3.4 Mexico Antiprotozoal Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antiprotozoal Drugs Revenue, 2017-2028
  6.4.2 Germany Antiprotozoal Drugs Market Size, 2017-2028
  6.4.3 France Antiprotozoal Drugs Market Size, 2017-2028
  6.4.4 U.K. Antiprotozoal Drugs Market Size, 2017-2028
  6.4.5 Italy Antiprotozoal Drugs Market Size, 2017-2028
  6.4.6 Russia Antiprotozoal Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Antiprotozoal Drugs Market Size, 2017-2028
  6.4.8 Benelux Antiprotozoal Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antiprotozoal Drugs Revenue, 2017-2028
  6.5.2 China Antiprotozoal Drugs Market Size, 2017-2028
  6.5.3 Japan Antiprotozoal Drugs Market Size, 2017-2028
  6.5.4 South Korea Antiprotozoal Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Antiprotozoal Drugs Market Size, 2017-2028
  6.5.6 India Antiprotozoal Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antiprotozoal Drugs Revenue, 2017-2028
  6.6.2 Brazil Antiprotozoal Drugs Market Size, 2017-2028
  6.6.3 Argentina Antiprotozoal Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antiprotozoal Drugs Revenue, 2017-2028
  6.7.2 Turkey Antiprotozoal Drugs Market Size, 2017-2028
  6.7.3 Israel Antiprotozoal Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Antiprotozoal Drugs Market Size, 2017-2028
  6.7.5 UAE Antiprotozoal Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Antiprotozoal Drugs Major Product Offerings
  7.1.4 Sanofi Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Akthelia Pharmaceuticals Ltd
  7.2.1 Akthelia Pharmaceuticals Ltd Corporate Summary
  7.2.2 Akthelia Pharmaceuticals Ltd Business Overview
  7.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Major Product Offerings
  7.2.4 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.2.5 Akthelia Pharmaceuticals Ltd Key News
7.3 GlaxoSmithKline Plc
  7.3.1 GlaxoSmithKline Plc Corporate Summary
  7.3.2 GlaxoSmithKline Plc Business Overview
  7.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Major Product Offerings
  7.3.4 GlaxoSmithKline Plc Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Plc Key News
7.4 Immuron Ltd
  7.4.1 Immuron Ltd Corporate Summary
  7.4.2 Immuron Ltd Business Overview
  7.4.3 Immuron Ltd Antiprotozoal Drugs Major Product Offerings
  7.4.4 Immuron Ltd Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.4.5 Immuron Ltd Key News
7.5 Microbiotix Inc
  7.5.1 Microbiotix Inc Corporate Summary
  7.5.2 Microbiotix Inc Business Overview
  7.5.3 Microbiotix Inc Antiprotozoal Drugs Major Product Offerings
  7.5.4 Microbiotix Inc Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.5.5 Microbiotix Inc Key News
7.6 Protein Potential LLC
  7.6.1 Protein Potential LLC Corporate Summary
  7.6.2 Protein Potential LLC Business Overview
  7.6.3 Protein Potential LLC Antiprotozoal Drugs Major Product Offerings
  7.6.4 Protein Potential LLC Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.6.5 Protein Potential LLC Key News
7.7 Dr. Reddy’s Laboratories
  7.7.1 Dr. Reddy’s Laboratories Corporate Summary
  7.7.2 Dr. Reddy’s Laboratories Business Overview
  7.7.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Major Product Offerings
  7.7.4 Dr. Reddy’s Laboratories Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.7.5 Dr. Reddy’s Laboratories Key News
7.8 Mission Pharmacal
  7.8.1 Mission Pharmacal Corporate Summary
  7.8.2 Mission Pharmacal Business Overview
  7.8.3 Mission Pharmacal Antiprotozoal Drugs Major Product Offerings
  7.8.4 Mission Pharmacal Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.8.5 Mission Pharmacal Key News
7.9 Aceto Corp.
  7.9.1 Aceto Corp. Corporate Summary
  7.9.2 Aceto Corp. Business Overview
  7.9.3 Aceto Corp. Antiprotozoal Drugs Major Product Offerings
  7.9.4 Aceto Corp. Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.9.5 Aceto Corp. Key News
7.10 Mylan Pharmaceuticals
  7.10.1 Mylan Pharmaceuticals Corporate Summary
  7.10.2 Mylan Pharmaceuticals Business Overview
  7.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
  7.10.4 Mylan Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.10.5 Mylan Pharmaceuticals Key News
7.11 Impax Laboratories
  7.11.1 Impax Laboratories Corporate Summary
  7.11.2 Impax Laboratories Business Overview
  7.11.3 Impax Laboratories Antiprotozoal Drugs Major Product Offerings
  7.11.4 Impax Laboratories Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.11.5 Impax Laboratories Key News
7.12 Pfizer
  7.12.1 Pfizer Corporate Summary
  7.12.2 Pfizer Business Overview
  7.12.3 Pfizer Antiprotozoal Drugs Major Product Offerings
  7.12.4 Pfizer Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.12.5 Pfizer Key News
7.13 Lupin Pharmaceuticals
  7.13.1 Lupin Pharmaceuticals Corporate Summary
  7.13.2 Lupin Pharmaceuticals Business Overview
  7.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
  7.13.4 Lupin Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.13.5 Lupin Pharmaceuticals Key News
7.14 Glenmark Pharmaceuticals
  7.14.1 Glenmark Pharmaceuticals Corporate Summary
  7.14.2 Glenmark Pharmaceuticals Business Overview
  7.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
  7.14.4 Glenmark Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.14.5 Glenmark Pharmaceuticals Key News
7.15 Sun Pharmaceutical
  7.15.1 Sun Pharmaceutical Corporate Summary
  7.15.2 Sun Pharmaceutical Business Overview
  7.15.3 Sun Pharmaceutical Antiprotozoal Drugs Major Product Offerings
  7.15.4 Sun Pharmaceutical Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.15.5 Sun Pharmaceutical Key News
7.16 Heritage Pharmaceuticals
  7.16.1 Heritage Pharmaceuticals Corporate Summary
  7.16.2 Heritage Pharmaceuticals Business Overview
  7.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
  7.16.4 Heritage Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.16.5 Heritage Pharmaceuticals Key News
7.17 Gilead Sciences
  7.17.1 Gilead Sciences Corporate Summary
  7.17.2 Gilead Sciences Business Overview
  7.17.3 Gilead Sciences Antiprotozoal Drugs Major Product Offerings
  7.17.4 Gilead Sciences Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.17.5 Gilead Sciences Key News
7.18 Johnson & Johnson
  7.18.1 Johnson & Johnson Corporate Summary
  7.18.2 Johnson & Johnson Business Overview
  7.18.3 Johnson & Johnson Antiprotozoal Drugs Major Product Offerings
  7.18.4 Johnson & Johnson Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.18.5 Johnson & Johnson Key News
7.19 Bristol-Myers Squibb
  7.19.1 Bristol-Myers Squibb Corporate Summary
  7.19.2 Bristol-Myers Squibb Business Overview
  7.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Major Product Offerings
  7.19.4 Bristol-Myers Squibb Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.19.5 Bristol-Myers Squibb Key News
7.20 Profounda
  7.20.1 Profounda Corporate Summary
  7.20.2 Profounda Business Overview
  7.20.3 Profounda Antiprotozoal Drugs Major Product Offerings
  7.20.4 Profounda Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.20.5 Profounda Key News
7.21 Knight Therapeutics
  7.21.1 Knight Therapeutics Corporate Summary
  7.21.2 Knight Therapeutics Business Overview
  7.21.3 Knight Therapeutics Antiprotozoal Drugs Major Product Offerings
  7.21.4 Knight Therapeutics Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.21.5 Knight Therapeutics Key News
7.22 Albert David
  7.22.1 Albert David Corporate Summary
  7.22.2 Albert David Business Overview
  7.22.3 Albert David Antiprotozoal Drugs Major Product Offerings
  7.22.4 Albert David Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.22.5 Albert David Key News
7.23 Wanlong
  7.23.1 Wanlong Corporate Summary
  7.23.2 Wanlong Business Overview
  7.23.3 Wanlong Antiprotozoal Drugs Major Product Offerings
  7.23.4 Wanlong Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.23.5 Wanlong Key News
7.24 Fangsheng
  7.24.1 Fangsheng Corporate Summary
  7.24.2 Fangsheng Business Overview
  7.24.3 Fangsheng Antiprotozoal Drugs Major Product Offerings
  7.24.4 Fangsheng Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.24.5 Fangsheng Key News
7.25 KPC Pharmaceuticals
  7.25.1 KPC Pharmaceuticals Corporate Summary
  7.25.2 KPC Pharmaceuticals Business Overview
  7.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
  7.25.4 KPC Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.25.5 KPC Pharmaceuticals Key News
7.26 Guilin Pharmaceuticals
  7.26.1 Guilin Pharmaceuticals Corporate Summary
  7.26.2 Guilin Pharmaceuticals Business Overview
  7.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Major Product Offerings
  7.26.4 Guilin Pharmaceuticals Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.26.5 Guilin Pharmaceuticals Key News
7.27 Pude Pharmaceutica
  7.27.1 Pude Pharmaceutica Corporate Summary
  7.27.2 Pude Pharmaceutica Business Overview
  7.27.3 Pude Pharmaceutica Antiprotozoal Drugs Major Product Offerings
  7.27.4 Pude Pharmaceutica Antiprotozoal Drugs Revenue in Global Market (2017-2022)
  7.27.5 Pude Pharmaceutica Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antiprotozoal Drugs Market Opportunities & Trends in Global Market
Table 2. Antiprotozoal Drugs Market Drivers in Global Market
Table 3. Antiprotozoal Drugs Market Restraints in Global Market
Table 4. Key Players of Antiprotozoal Drugs in Global Market
Table 5. Top Antiprotozoal Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antiprotozoal Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antiprotozoal Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antiprotozoal Drugs Product Type
Table 9. List of Global Tier 1 Antiprotozoal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiprotozoal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antiprotozoal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antiprotozoal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antiprotozoal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antiprotozoal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antiprotozoal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antiprotozoal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antiprotozoal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antiprotozoal Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antiprotozoal Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antiprotozoal Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antiprotozoal Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antiprotozoal Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antiprotozoal Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antiprotozoal Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Antiprotozoal Drugs Product Offerings
Table 32. Sanofi Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Akthelia Pharmaceuticals Ltd Corporate Summary
Table 34. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product Offerings
Table 35. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Plc Corporate Summary
Table 37. GlaxoSmithKline Plc Antiprotozoal Drugs Product Offerings
Table 38. GlaxoSmithKline Plc Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Immuron Ltd Corporate Summary
Table 40. Immuron Ltd Antiprotozoal Drugs Product Offerings
Table 41. Immuron Ltd Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Microbiotix Inc Corporate Summary
Table 43. Microbiotix Inc Antiprotozoal Drugs Product Offerings
Table 44. Microbiotix Inc Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Protein Potential LLC Corporate Summary
Table 46. Protein Potential LLC Antiprotozoal Drugs Product Offerings
Table 47. Protein Potential LLC Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Dr. Reddy’s Laboratories Corporate Summary
Table 49. Dr. Reddy’s Laboratories Antiprotozoal Drugs Product Offerings
Table 50. Dr. Reddy’s Laboratories Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Mission Pharmacal Corporate Summary
Table 52. Mission Pharmacal Antiprotozoal Drugs Product Offerings
Table 53. Mission Pharmacal Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Aceto Corp. Corporate Summary
Table 55. Aceto Corp. Antiprotozoal Drugs Product Offerings
Table 56. Aceto Corp. Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Mylan Pharmaceuticals Corporate Summary
Table 58. Mylan Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 59. Mylan Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Impax Laboratories Corporate Summary
Table 61. Impax Laboratories Antiprotozoal Drugs Product Offerings
Table 62. Impax Laboratories Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer Antiprotozoal Drugs Product Offerings
Table 65. Pfizer Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Lupin Pharmaceuticals Corporate Summary
Table 67. Lupin Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 68. Lupin Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Glenmark Pharmaceuticals Corporate Summary
Table 70. Glenmark Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 71. Glenmark Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Sun Pharmaceutical Corporate Summary
Table 73. Sun Pharmaceutical Antiprotozoal Drugs Product Offerings
Table 74. Sun Pharmaceutical Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Heritage Pharmaceuticals Corporate Summary
Table 76. Heritage Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 77. Heritage Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Gilead Sciences Corporate Summary
Table 79. Gilead Sciences Antiprotozoal Drugs Product Offerings
Table 80. Gilead Sciences Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 81. Johnson & Johnson Corporate Summary
Table 82. Johnson & Johnson Antiprotozoal Drugs Product Offerings
Table 83. Johnson & Johnson Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 84. Bristol-Myers Squibb Corporate Summary
Table 85. Bristol-Myers Squibb Antiprotozoal Drugs Product Offerings
Table 86. Bristol-Myers Squibb Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 87. Profounda Corporate Summary
Table 88. Profounda Antiprotozoal Drugs Product Offerings
Table 89. Profounda Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 90. Knight Therapeutics Corporate Summary
Table 91. Knight Therapeutics Antiprotozoal Drugs Product Offerings
Table 92. Knight Therapeutics Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 93. Albert David Corporate Summary
Table 94. Albert David Antiprotozoal Drugs Product Offerings
Table 95. Albert David Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 96. Wanlong Corporate Summary
Table 97. Wanlong Antiprotozoal Drugs Product Offerings
Table 98. Wanlong Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 99. Fangsheng Corporate Summary
Table 100. Fangsheng Antiprotozoal Drugs Product Offerings
Table 101. Fangsheng Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 102. KPC Pharmaceuticals Corporate Summary
Table 103. KPC Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 104. KPC Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 105. Guilin Pharmaceuticals Corporate Summary
Table 106. Guilin Pharmaceuticals Antiprotozoal Drugs Product Offerings
Table 107. Guilin Pharmaceuticals Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)
Table 108. Pude Pharmaceutica Corporate Summary
Table 109. Pude Pharmaceutica Antiprotozoal Drugs Product Offerings
Table 110. Pude Pharmaceutica Antiprotozoal Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Antiprotozoal Drugs Segment by Type in 2021
Figure 2. Antiprotozoal Drugs Segment by Application in 2021
Figure 3. Global Antiprotozoal Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antiprotozoal Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antiprotozoal Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiprotozoal Drugs Revenue in 2021
Figure 8. By Type - Global Antiprotozoal Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antiprotozoal Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antiprotozoal Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antiprotozoal Drugs Revenue Market Share, 2017-2028
Figure 12. US Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antiprotozoal Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antiprotozoal Drugs Revenue Market Share, 2017-2028
Figure 24. China Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antiprotozoal Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antiprotozoal Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antiprotozoal Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Plc Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Immuron Ltd Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Microbiotix Inc Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Protein Potential LLC Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dr. Reddy’s Laboratories Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mission Pharmacal Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Aceto Corp. Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mylan Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Impax Laboratories Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pfizer Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Lupin Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Glenmark Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Sun Pharmaceutical Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Heritage Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Gilead Sciences Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Johnson & Johnson Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Bristol-Myers Squibb Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Profounda Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Knight Therapeutics Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Albert David Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Wanlong Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Fangsheng Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. KPC Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Guilin Pharmaceuticals Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Pude Pharmaceutica Antiprotozoal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)